Can a Blood Clot Be Surgically Removed?

Blood clots can be surgically removed, and in many situations they routinely are. The specific technique depends on where the clot is lodged: in a brain artery, a lung vessel, a leg vein, or elsewhere. Some procedures involve traditional open surgery with a scalpel and sutures, but the field has shifted heavily toward catheter-based methods, where a thin tube is threaded through a blood vessel to reach the clot and pull, suction, or dissolve it from the inside. The medical umbrella term is “thrombectomy,” and it has become standard care for several life-threatening clot emergencies, though the evidence for it varies dramatically depending on which part of the body is involved.

Stroke and the Brain

The most dramatic success story for clot removal is in acute ischemic stroke, the kind caused by a large clot blocking a major brain artery. When that happens, brain tissue begins dying within minutes, and the goal is to reopen the vessel as fast as possible. For strokes caused by a large-vessel occlusion in the front part of the brain’s circulation, mechanical thrombectomy has become the standard of care. Guidelines from the American Heart Association recommend it for eligible patients who can have the procedure started within six hours of symptom onset, based on the highest level of clinical evidence.

The results are striking. A meta-analysis of randomized trials found that thrombectomy roughly doubled the chances of functional independence at 90 days compared with medical treatment alone and improved the odds of being able to walk independently, without a significant increase in early death or dangerous brain bleeding.¹ Even for patients with very large strokes, where the outlook used to be considered hopeless, a major trial found that about 20% of patients who received thrombectomy achieved functional independence, compared with 7% in the medical-care-only group.²

There is also growing evidence that some patients can benefit even beyond the six-hour window. Advanced brain imaging can identify people whose brain tissue is still salvageable up to 24 hours after symptom onset, usually because they have strong collateral blood flow that has kept the tissue alive longer than average.³ A meta-analysis of treatment in this extended window confirmed that thrombectomy’s benefit holds up in patients selected through such imaging, though the apparent preserved benefit likely reflects careful patient selection rather than the clock being irrelevant.⁴ Neuroimaging plays a central role in deciding who qualifies for the procedure in both the early and late windows.⁵

Blood Clots in the Lungs

A pulmonary embolism, where a clot travels to the lungs and blocks blood flow, is another scenario where clot removal can be life-saving. Treatment depends on how severe the blockage is. For patients with massive pulmonary embolism who are in shock or whose heart is failing, open surgical embolectomy (physically cutting open the pulmonary artery to remove the clot) has been performed for decades. A meta-analysis of surgical embolectomy outcomes found that the vast majority of patients had right heart dysfunction and unstable blood pressure going in. In-hospital mortality was about 16%, which sounds high until you consider that these patients were often on the verge of cardiac arrest. Five-year survival for those who made it through was around 73%.⁶

Catheter-based approaches are increasingly used for intermediate-risk pulmonary embolism, where the heart is strained but the patient is not in full shock. One system, the FlowTriever, works by suctioning clot material directly out of the pulmonary arteries through a large catheter. A multicenter trial of this device showed that it reduced the strain on the right side of the heart by about 25% within 48 hours, with a low rate of major bleeding and no need for intensive care in over 40% of patients.⁷ A more recent head-to-head trial (PEERLESS) compared large-bore mechanical thrombectomy against catheter-directed thrombolysis, where clot-dissolving drugs are infused directly at the clot site. Mechanical thrombectomy performed better on a composite endpoint driven by lower rates of clinical deterioration and less need for ICU stays afterward, with no significant difference in mortality or major bleeding between the two approaches.⁸

Clots in Leg Arteries

Acute limb ischemia happens when a clot suddenly blocks blood flow to an arm or leg. Without rapid treatment, the limb can be lost. For decades, the go-to procedure was a surgical thrombectomy using a Fogarty balloon catheter: a surgeon makes a small incision, threads a catheter past the clot, inflates a tiny balloon at the tip, and pulls the clot out like pulling a cork from a bottle. This technique, introduced in the 1960s, is still widely used.

Endovascular alternatives have caught up. A large propensity-matched analysis of nearly 7,800 patients found that those who received endovascular treatment had lower in-hospital mortality (about 2.8% versus 4.0%), fewer heart attacks, less need for fasciotomy (a surgical procedure to relieve dangerous swelling), and less major bleeding than those who had open surgery. Amputation rates were similar between the two groups.⁹ A systematic review and meta-analysis of clinical trials comparing the two approaches found no significant difference in death rates or amputation rates at one month, six months, or one year, suggesting that for most patients the outcomes are broadly comparable.¹⁰ The choice often comes down to the specific anatomy, how accessible the clot is, and what expertise is available at the hospital.

In some cases, a percutaneous Fogarty catheter approach can serve as a rescue option when other endovascular techniques fail to clear a stubborn clot.¹¹

Deep Vein Thrombosis

Clots in the deep veins of the legs (DVT) are extremely common and most are treated with blood-thinning medication alone. But when a clot is large, fresh, and causing severe symptoms, or when it threatens to break off and travel to the lungs, mechanical thrombectomy is sometimes used. A retrospective study found that thrombectomy was effective at restoring normal blood flow through the vein, preventing recurrence of DVT, and reducing the risk of post-thrombotic syndrome, the chronic pain, swelling, and skin changes that plague many DVT survivors.¹² This application is not as universally established as stroke thrombectomy, and guidelines vary on when to recommend it versus anticoagulation alone.

Heart Attacks Are the Exception

Given how well clot removal works in stroke, you might expect the same for heart attacks, where a clot blocks a coronary artery. Surprisingly, the evidence says otherwise. During a heart attack procedure (primary percutaneous coronary intervention, or PCI), the standard approach is to thread a catheter to the blocked coronary artery and place a stent to hold it open. Adding routine manual thrombectomy, where the clot is suctioned out before stenting, was once widely practiced because it seemed logical and some early data supported it. A smaller trial found that thrombus aspiration improved blood flow to the heart muscle at the microscopic level and reduced the size of the damaged area at three months.¹³

But the definitive answer came from a much larger trial involving over 10,000 patients. Routine manual thrombectomy during heart attack PCI did not reduce the combined risk of cardiovascular death, recurrent heart attack, cardiogenic shock, or severe heart failure within 180 days. Worse, it was linked to a doubling in the rate of stroke within 30 days.¹⁴ An individual-patient-level meta-analysis confirmed that routine thrombus aspiration during heart attack PCI does not improve clinical outcomes overall, though it noted a trend toward possible benefit in patients with very high clot burden that could justify further research with better devices.¹⁵ As a result, routine thrombectomy during heart attack PCI has largely fallen out of favor, though it may still be used selectively in specific situations with massive clot.

How the Devices Actually Work

For brain clots, two main device categories dominate. Stent retrievers are small mesh tubes delivered inside a catheter to the clot site. Once released, the stent self-expands within the clot, pushing it against the artery wall and immediately restoring some blood flow in most cases. After a few minutes, the stent, with the clot trapped in its mesh, is pulled back into the catheter and removed from the body.¹⁶ Lab testing has shown that the stent interacts with the clot somewhat superficially, pushing it against the vessel wall and dragging it along rather than deeply ensnaring it.¹⁷

Aspiration catheters take a different approach. A large-bore catheter is advanced to the clot, and an electric pump creates negative pressure to suction the clot into the catheter. Some systems use a separator wire that fragments the clot into smaller pieces, which are then vacuumed out. The advantage of aspiration is that it can reduce the risk of sending clot fragments downstream into smaller vessels.¹⁶ In practice, many procedures combine both techniques.

What the Clot Is Made Of Matters

Not all blood clots are the same, and their internal makeup affects how easily they can be removed. Clots rich in red blood cells tend to be softer and easier to grab or suction. Clots heavy in fibrin, the tough protein mesh that forms the structural scaffold of a clot, are firmer and more resistant to removal. In stroke thrombectomy, fibrin-rich clots have been associated with the need for more retrieval attempts, longer procedures, and less favorable outcomes.¹⁸

Doctors can sometimes get clues about clot composition before the procedure. On a standard CT scan, a bright “hyperdense artery sign” in the blocked vessel tends to correlate with mixed-composition clots that have lower fibrin content, while clots without that bright signal tend to have higher fibrin content.¹⁹ This kind of pre-procedure imaging information can help the treatment team anticipate how difficult the extraction will be and adjust their device choice accordingly.

Risks and Complications

Pulling or suctioning a clot out of a blood vessel is not without hazards. The most common concern is distal embolization: during retrieval, pieces of the clot can break off and travel further downstream, blocking smaller vessels. Every thrombectomy device tested in lab models has produced some degree of micro- and macro-fragments during use.²⁰ Device design makes a difference. Newer stent retrievers with a filter tip prevented clot fragments larger than 1 mm from reaching downstream territory in about 44% of cases, compared with about 16-20% for standard designs.²¹

Distal embolization is not just a theoretical problem in the brain. In pulmonary embolism procedures using catheter fragmentation, downstream clot migration was confirmed by angiography in about a third of patients in one study, and it caused a temporary rise in pulmonary artery pressure in that group. Aspiration afterward brought pressures back down.²²

Vessel wall injury is another concern, particularly in the brain’s delicate arteries. Animal studies and post-procedure tissue analysis have shown that the mechanical force of retrieving a clot can damage the inner lining of the artery.²³ A study examining failure modes found that pulling the device back could cause the artery to stretch, and in severe cases, small perforating arteries branching off the main vessel could be torn.²⁴ These risks are part of why patient selection criteria exist: the benefit has to outweigh these potential harms, which is why thrombectomy is reserved for large-vessel blockages causing significant deficits rather than being used for every small clot.

Anesthesia During Stroke Thrombectomy

An unexpected area of debate is whether patients undergoing brain thrombectomy should be fully asleep under general anesthesia or sedated but conscious. This question matters because general anesthesia can drop blood pressure, which is particularly dangerous when brain tissue is already starved for blood flow. An early observational study found that patients under general anesthesia had significantly higher in-hospital mortality (25% versus 12%) and more pneumonia than those under conscious sedation.²⁵

However, those observational numbers were misleading. Sicker patients were more likely to be put under general anesthesia in the first place, skewing the comparison. When randomized trials were conducted, the picture changed. A meta-analysis of randomized trials found that general anesthesia was actually associated with higher odds of functional independence and more successful clot removal, though it carried a much higher risk of significant blood pressure drops during the procedure.²⁶ A more recent meta-analysis of eight randomized trials confirmed higher recanalization success with general anesthesia but found no significant difference in functional recovery, mortality, pneumonia, or brain hemorrhage between the two approaches.²⁷ The current thinking is that general anesthesia is safe in experienced centers with careful blood-pressure management, but the debate is not fully settled.

Getting to a Hospital That Can Do It

One of the biggest practical barriers to clot removal is geography. Not every hospital has the equipment, trained specialists, or around-the-clock staffing to perform mechanical thrombectomy. For stroke, where every minute of delay costs brain tissue, this is a particularly acute problem. A study of thrombectomy access in the United States found stark disparities: about 36% of stroke patients in the most rural counties initially arrived at a hospital that could not perform thrombectomy, compared with only about 7% of patients in the most urban counties. Patients in major urban areas were far more likely to reach a thrombectomy-capable hospital directly, and this gap persisted even after accounting for other demographic differences.²⁸

Volume also matters. A Florida-based study found that if you required hospitals to perform at least 15 thrombectomies per year to be considered a capable center, the share of stroke patients living within a one-hour drive of such a center dropped from 87% to 77%.²⁹ Higher-volume centers generally have better outcomes, so the trade-off between proximity and expertise is real. Transfer protocols, where a local hospital stabilizes the patient and rapidly transfers them to a thrombectomy center, have become a critical part of the system. For people living far from a major medical center, understanding this transfer pathway matters. If you or someone near you is having stroke symptoms, calling emergency services rather than driving to the nearest small hospital is important, because the ambulance system is designed to route patients to the right level of care.

Dialysis Grafts and Other Niche Applications

Thrombectomy is not limited to emergency scenarios. One common but less dramatic application involves clotted dialysis access grafts, the surgically created blood vessel connections that kidney dialysis patients depend on. When these grafts clot off, they need to be reopened quickly so dialysis can continue. A meta-analysis comparing surgical thrombectomy to catheter-based approaches for clotted dialysis grafts found that surgery had a clear advantage at every time point measured, from 30 days out to one year. The rate of technical failure was also nearly double with endovascular approaches compared with surgery.³⁰ This is one area where old-fashioned open surgery still outperforms the newer catheter techniques, likely because the graft is easily accessible and the surgeon can directly address any underlying narrowing at the same time.